Lapatinib Plus Trastuzumab Improves Survival in Metastatic Breast Cancer
August 20th 2012In patients with heavily pretreated HER2-positive metastatic breast cancer, combination treatment with lapatinib and trastuzumab was associated with a median survival benefit of 4.5 months, according to the final results of a phase III study.
Managing Elevated Lead Levels in Pregnancy
August 17th 2012Because lead easily crosses the placenta, elevated lead levels in pregnancy have been associated with gestational hypertension, spontaneous abortion, low birth weight, and impaired neurodevelopment. In a new Committee Opinion, The American College of Obstetricians and Gynecologists has reviewed screening and management policies for elevated lead levels in pregnancy.
Timing of Endometrial Injury Matters in ART
August 15th 2012In women undergoing assisted reproductive techniques, intentional endometrial injury performed in the month prior to the embryo transfer cycle can increase the likelihood of clinical pregnancy and live birth, according to results of a new study.
A new option for preventing HIV in women?
August 2nd 2012Researchers are about to launch a large, multinational Phase III clinical trial to test the safety and effectiveness of a vaginal ring containing the experimental antiretroviral (ARV) drug dapivirine. The ring is intended to provide women with another means to prevent HIV acquisition through vaginal intercourse.
Cranberry for UTIs: not just folklore
July 20th 2012Cranberry-containing products may be more than just a folk remedy for urinary tract infections (UTIs). A systematic review and meta-analysis published in the Archives of Internal Medicine concludes that cranberry-containing products offer women protection against UTIs, particularly those prone to recurrent infections.
Embolization for Uterine Fibroids Has Benefits, But Still Impacts Reproductive Potential
July 18th 2012In a systematic review of UAE versus other surgical interventions for symptomatic uterine fibroids, researchers concluded that UAE offers substantial improvements in symptoms of uterine fibroids but may not help women who want to retain their reproductive potential.